Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Canada Signs Deal for 1 Mln Doses of Pfizer Covid Antiviral and 500K Merck's Covid Pill

12/03/2021 | 01:49pm EST


ę MT Newswires 2021
All news about PFIZER, INC.
08:23aBillionaire Soon-Shiong opens new vaccine plant in South Africa
RE
07:38aEssa Pharma Commences Dosing in Phase 1/2 Clinical Trial of Prostate Cancer Combo Thera..
MT
06:25aTony Wood appointed Chief Scientific Officer designate, GSK
AQ
06:02aCARBON NEUTRAL BY 2030 : How Pfizer is Fighting Climate Change with Ambitious Science Base..
PU
05:18aValneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
02:16aGlaxoSmithKline Names Chief Scientific Officer Designate
MT
01:27aPfizer chief Albert Bourla wins $1 million Genesis Prize
AQ
12:40aEMEA MORNING BRIEFING : Shares to Tumble Again as -2-
DJ
01/18S&P Flags Unilever for Downgrade on Proposal to Buy GSK/Pfizer's Consumer Healthcare Ar..
MT
01/18Fourth Pfizer-BioNTech COVID-19 Shot Fails to Prevent Omicron Infection in Israeli Stud..
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 916 M - -
Net income 2021 22 210 M - -
Net Debt 2021 27 661 M - -
P/E ratio 2021 14,2x
Yield 2021 2,93%
Capitalization 304 B 304 B -
EV / Sales 2021 4,05x
EV / Sales 2022 3,26x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 54,11 $
Average target price 57,14 $
Spread / Average Target 5,60%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-8.37%303 712
JOHNSON & JOHNSON-2.32%439 907
ROCHE HOLDING AG-3.75%322 066
ABBVIE INC.1.02%241 811
ELI LILLY AND COMPANY-10.55%223 992
NOVO NORDISK A/S-13.80%219 759